Literature DB >> 33522575

Clinical presentation of incident syphilis among men who have sex with men taking HIV Pre-Exposure Prophylaxis in Melbourne, Australia.

Joanne Peel1, Eric P F Chow1,2,3, Ian Denham1, Tina Schmidt1, Andrew Buchanan1, Christopher Fairley1,2, Deborah A Williamson4,5,6, Melanie Bissessor1, Marcus Y Chen1,2.   

Abstract

BACKGROUND: Current international guidelines on HIV Pre-Exposure Prophylaxis (PrEP) recommend serological screening for syphilis at routine three-monthly PrEP appointments. The aim of our study was to describe the pattern of clinical presentation of syphilis among men who have sex with men (MSM) taking PrEP. We were interested in whether syphilis is detected through screening at scheduled three-monthly PrEP clinic appointments or whether primary or secondary syphilis presented at unscheduled interval visits.
METHODS: This was a retrospective study of MSM attending the PrEP clinic at the Melbourne Sexual Health Centre between February 2016 and March 2019. Serological screening for syphilis was routinely undertaken at three-monthly PrEP clinic appointments. Diagnoses of early syphilis were identified from PrEP clinic visits and from interim walk-in STI clinic attendances.
RESULTS: There were 69 cases of early syphilis among 61 MSM taking PrEP during the study period. There were 24 (35%) primary, 16 (23%) secondary and 29 (42%) early latent infections. The incidence of early syphilis was 8.6 per 100 person-years. A substantial proportion of primary (58%) and secondary (44%) syphilis diagnoses were made at interim STI clinic attendances, between PrEP appointments.
CONCLUSIONS: Syphilis screening at routine three-monthly PrEP visits alone fails to detect a proportion of primary and secondary syphilis infections and may be insufficient in preventing onward transmission. Education of MSM taking PrEP regarding the risk of syphilis and symptom recognition is necessary together with access to syphilis testing between PrEP visits.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Year:  2021        PMID: 33522575     DOI: 10.1093/cid/ciab052

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  A cross-sectional survey on attitudes of men who have sex with men towards anal self-examination for detection of anal syphilis.

Authors:  Ei T Aung; Christopher K Fairley; Jason J Ong; Tiffany R Phillips; Marcus Y Chen; Julien Tran; Kate Maddaford; Elena R Rodriguez; Eric P F Chow
Journal:  Sci Rep       Date:  2022-05-27       Impact factor: 4.996

2.  Nonclassical Pathogens as Causative Agents of Proctitis in Men who Have Sex With Men.

Authors:  Eric P F Chow; Darren Lee; Stephanie Bond; Christopher K Fairley; Kate Maddaford; Rebecca Wigan; Glenda Fehler; Sigrid A Lange; Vesna De Petra; Melanie Bissessor; Catriona S Bradshaw; Benjamin P Howden; Jane S Hocking; Deborah A Williamson; Marcus Y Chen
Journal:  Open Forum Infect Dis       Date:  2021-03-19       Impact factor: 3.835

3.  Preferences of men who have sex with men for performing anal self-examination for the detection of anal syphilis in Australia: A discrete choice experiment.

Authors:  Ei T Aung; Eric P F Chow; Christopher K Fairley; Tiffany R Phillips; Marcus Y Chen; Julien Tran; Kate Maddaford; Elena R Rodriguez; Jason J Ong
Journal:  Lancet Reg Health West Pac       Date:  2022-02-23

4.  Adherence to weekly anal self-examination among men who have sex with men for detection of anal syphilis.

Authors:  Ei T Aung; Christopher K Fairley; Jason J Ong; Tiffany P Phillips; Julien Tran; Marcus Y Chen; Kate Maddaford; Eric P F Chow
Journal:  Front Med (Lausanne)       Date:  2022-08-01

5.  Non-conventional interventions to prevent gonorrhea or syphilis among men who have sex with men: A scoping review.

Authors:  Julien Tran; Christopher K Fairley; Henry Bowesman; Ei T Aung; Jason J Ong; Eric P F Chow
Journal:  Front Med (Lausanne)       Date:  2022-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.